Requirement 1: A formula (1) compound for cancer treatment, in which the treatment of cancer is modulated by the immune response, including the recovery of the tumor's immune system； The compound can be used in combination with one or more chemotherapeutics and/or radiotherapy and/or directional therapy； in formula compound (1): formula fragment (2), it is replaced by R 2.R2 represents hydrogen, C83218331838324 tar, halogen or cyanide, and (R1) 8345 can be used instead.(R1) C8345； stands for 1, 2 or 3 alternatives, in which R1 alternatives should be independently from C83218C83331C833183238Alcoy, CCs-3183331C832318FLUOAL Quilo, C83218331833238FLUOAL Loxic, or Ciano； X stands for S-O； R3 stands for C8323232323233； A. Methyl or trifluoroiodine； r8308； 74919 and R8308； 74955 stand for hydrogen, methyl or R8308； 7491 and R8308； 74919 and R8308； 7495 and the carbon atoms attached to them represent a bicycle-1, 1-diilo group； R8309； 7491 and R8309； 74959 stand for hydrogen, methyl or R83747491y independently； R8309, 74959, and the associated carbon atoms represent a cyclopropane-1,1-diacyl group.AR1 represents phenyl, or a heteromorphic form of 5 or 6 members, of which 5 or 6 members are phenyl or heteromorphic independent.D.Di-o Trisustitute, in which C832183.31832626 tar, C832183.318324alcoy, C83218331238FLUQUIL, C8321218331833238FLU, C832123238FLU hydrogen XI, C8321833183323238FLO were selected independently. C.C8323833183626 cycloquilo, in which C832383318332626 cycloquilo was not replaced or MONO-substituted by aminobenzene； C832483318326cycloquilo contained epoxy atoms, and C832483318326cycloquilo contained epoxy atoms was not replaced or replaced. E. On hydroxi； C83238331326 Ccyclo-oxi； hydroxi； X1-CO-Ro1；X1 stands for direct link, C8321832323 lessor, -O-C832183318323 lessor, **,- NH-C832183.31832323 tar-*；- S-CH832222-**-CF8322-,-CH=CH---Ch...-NH-CO-**- I...O C83238331； 8325 cycloquileno, in which asterisks are associated with the CO-RO1 group；Y Ro1 stands for --
